Vanguard Group Inc Cytosorbents Corp Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,949,551 shares of CTSO stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,949,551
Previous 1,949,551
-0.0%
Holding current value
$2.24 Million
Previous $2.92 Million
40.01%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.56 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.2 Million0.38% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.93 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.44 Million0.18% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.2MShares$1.39 Million0.05% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $50.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...